Details of the Drug Formulaction

General Information of Drug Formulation (ID: F21009)

• Formulation Name: Tetrabenazine 25 mg tablet
• Company: Camber Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Tetrabenazine	(DMYWQ0O)	Huntington disease	8A01.10	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Sodium stearyl fumarate	(E00545)	23665634	lubricant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant